643 results
Page 16 of 33
8-K
EX-99.2
48jc2u 4yshg473ti0yg
15 Sep 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
agfz7i yy
4 Aug 10
Discovery Labs Provides Business Update and Reports Second Quarter 2010 Financial Results
12:00am
8-K
7cfbu5b5ctnldb
4 Aug 10
Discovery Labs Provides Business Update and Reports Second Quarter 2010 Financial Results
12:00am
424B5
fek2ceixw
18 Jun 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
qfwlr
17 Jun 10
Discovery Labs Prices $10.0 Million Public Offering of
12:00am
424B5
4x5jo8kzhkt0ynh
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
4o87pgyrik1010evy3e7
15 Jun 10
Prospectus supplement
12:00am
8-K
EX-10.1
xzz4xrczp5kb2
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
lgf16
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
epht0v
9 Jun 10
Discovery Labs Reports Preliminary Results from Phase 2 Clinical Trial of Surfaxin in Pediatric Acute Respiratory Failure
12:00am
8-K
EX-99.1
7sn0y7
9 Jun 10
Discovery Labs Receives FDA Guidance Regarding Preclinical Program to
12:00am
8-K
bkgs7ew0
4 Jun 10
Discovery Labs Announces Listing Transfer to NASDAQ Capital Market
12:00am
8-K
EX-99.1
uv9fuadbxu1
4 Jun 10
Discovery Labs Announces Listing Transfer to NASDAQ Capital Market
12:00am
8-K
zhl8b3wy19cwk
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am
8-K
EX-99.1
sd876
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am
8-K
wpvn 8uwx05
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
8-K
EX-99.1
8fj7y
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am